Orion Portfolio Solutions LLC Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Orion Portfolio Solutions LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,059 shares of the medical equipment provider’s stock after purchasing an additional 204 shares during the period. Orion Portfolio Solutions LLC’s holdings in Intuitive Surgical were worth $6,816,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of ISRG. Vanguard Group Inc. increased its stake in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the period. State Street Corp boosted its holdings in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. Geode Capital Management LLC increased its position in Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the period. Fisher Asset Management LLC raised its holdings in Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $2,401,493,000. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on ISRG shares. Robert W. Baird decreased their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 3.2 %

Shares of ISRG opened at $491.84 on Friday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a market capitalization of $175.18 billion, a P/E ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm has a 50 day moving average of $556.28 and a 200 day moving average of $532.68.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.